Medinotec (MDNC) Net Cash Flow (2022 - 2026)
Medinotec (MDNC) posted Net Cash Flow of -$216475.0 for Q2 2026, down 189.12% on a QoQ basis from -$74873.0 in Q1 2026, and up 72.84% year-over-year from -$125243.4 in Q2 2025.
Medinotec (MDNC) Net Cash Flow (2022 - 2026) Analysis & Trends
Medinotec's Net Cash Flow history runs 5 years deep, the most recent figure standing at -$216475.0 for Q2 2026.
- Quarterly Net Cash Flow rose 72.84% year-over-year to -$216475.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $550231.0 (up 258.13% YoY) and the FY2026 annual result came in at -$31795.0, down 119.78% from the prior year.
- Net Cash Flow was -$216475.0 for Q2 2026 at Medinotec, down from -$74873.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $3.4 million in Q2 2022 and bottomed at -$797138.0 in Q2 2025.
- A 5-year average of $140968.9 and a median of -$46417.0 in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow slumped 449.92% — and 2025, when it surged 3221.25%.
- Medinotec's Net Cash Flow stood at -$541651.0 in 2022, then soared by 70.28% to -$160965.0 in 2023, then jumped by 88.84% to -$17961.0 in 2024, then jumped by 3221.25% to $560608.0 in 2025, then plunged by 138.61% to -$216475.0 in 2026.
- Business Quant data shows MDNC's Net Cash Flow at -$216475.0 in Q2 2026, -$74873.0 in Q1 2026, and $560608.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | -216,475.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -216,475.00 |
| May 31, 2026 | -216,475.00 |
| Feb 28, 2026 | -74,873.00 |
| Feb 28, 2026 | -74,873.00 |
| Nov 30, 2025 | 560,608.00 |
| Nov 30, 2025 | 560,608.00 |
| Aug 31, 2025 | 280,971.00 |
| Aug 31, 2025 | 280,971.00 |
| May 31, 2025 | -797,138.00 |
| May 31, 2025 | -797,138.00 |
| Feb 28, 2025 | 275,676.00 |
| Feb 28, 2025 | 275,676.00 |
| Nov 30, 2024 | -17,961.00 |
| Nov 30, 2024 | -17,961.00 |
| Aug 31, 2024 | 191,470.00 |
| Aug 31, 2024 | 191,470.00 |
| May 31, 2024 | -288,465.00 |
| May 31, 2024 | -288,465.00 |
| Feb 29, 2024 | 198,446.00 |
| Feb 29, 2024 | 198,446.00 |